CMS issues proposed rule for health insurance marketplace guidelines

The Centers for Medicare & Medicaid Services (CMS) has released a proposed rule outlining program integrity guidelines for the Health Insurance Marketplace (Marketplace) and premium stabilization programs.

Through the Affordable Care Act, consumers and small businesses will have access to new marketplaces where they can access quality, affordable private health insurance. Consumers in every state will be able to buy insurance from qualified health plans directly through these marketplaces and may be eligible for tax credits to lower the cost of their health insurance.  

“In just a few months, consumers across the country will have access to a new marketplace in their state where they can easily shop for health insurance that meets their needs and the needs of their families,” said CMS Administrator Marilyn Tavenner. “The release of these guidelines signals that we’re ready to build on our ongoing efforts and ensure that the new systems are fiscally sound.”

Many of the provisions in today’s rule build on guidance previously issued to states and other key stakeholders. The policies offer clarity on oversight of various premium stabilization and affordability programs, build on state options regarding the Small Business Health Options Program, and provide technical clarifications.

With open enrollment only a few months away, consumers can look forward to receiving more information in the coming weeks and months about how to enroll in the marketplace.

CMS will re-launch HealthCare.gov this summer so consumers can access real-time information and help to sign up for coverage during open enrollment in October.

The marketplace call center will begin taking calls from consumers, beginning with educational information and then assisting with enrollment and plan selection on October 1. CMS will also begin consumer assistance training this summer so that consumers will have the help they need in applying for and choosing the coverage that is right for them.

The agency has made the proposed rule and a fact sheet available online.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.